Amicus To See If Its Fabry Drug Galafold Can Benefit From Mis-Diagnosed MS

 
• By Sten Stovall
  
Occupational therapy
Amicus to target multiple sclerosis centers as Fabry can be mis-diagnosed as MS. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip